# Clinical Assessment of Itraconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel

> **NCT04110834** · PHASE2 · COMPLETED · sponsor: **Sara Botros** · enrollment: 30 (actual)

## Conditions studied

- Tinea Versicolor

## Interventions

- **DRUG:** itraconazole gel once daily
- **DRUG:** itraconazole gel twice daily
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT04110834
- **Lead sponsor:** Sara Botros
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-15
- **Primary completion:** 2018-06-20
- **Final completion:** 2018-06-30
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04110834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04110834, "Clinical Assessment of Itraconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04110834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*